SCHEMBL2378148

SCHEMBL2378148

O=C(O)CCCC=CCCc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 1/20 0.72
HDAC3 O15379 1/20 0.66
MAPK1 P28482 1/20 0.66
ADRA1A P35348 1/20 0.66
HDAC4 P56524 1/20 0.66
SLC6A3 Q01959 1/20 0.66
HDAC1 Q13547 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
HDAC7 Q8WUI4 1/20 0.66
HDAC2 Q92769 1/20 0.66
HDAC10 Q969S8 1/20 0.66
HDAC11 Q96DB2 1/20 0.66
HDAC8 Q9BY41 1/20 0.66
HDAC6 Q9UBN7 1/20 0.66
HDAC9 Q9UKV0 1/20 0.66
HDAC5 Q9UQL6 1/20 0.66
MAPT P10636 2/20 0.61
RXFP1 Q9HBX9 1/20 0.61
GPR52 Q9Y2T5 4/20 0.59
KEAP1 Q14145 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2378147 1.00 TOP1 (0.72) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL10986050 1.00 TOP1 (0.72) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL7991496 0.95 TOP1 (0.65) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL10533519 0.93 TOP1 (0.72) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL6758436 0.89 KEAP1 (0.63) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL7738550 0.89 KEAP1 (0.63) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL7738555 0.89 KEAP1 (0.63) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL6759998 0.89 KEAP1 (0.63) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL6758432 0.89 KEAP1 (0.63) TOP1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL6763471 0.87 MAPT (0.70) TOP1HDAC3MAPK1ADRA1AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026280-B2 For therapy of cancer, hematological disorders, e.g., hemoglobinopathies, and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy. ERRANT GENE THERAPEUTICS, LLC (US) 2011-09-27 US claimed
WO-2009113320-A1 MMP INHIBITOR 株式会社ヤクルト本社 (JP) 2009-09-17 WO disclosed
US-4513005-A SULFIDE OR SULFONE HYDROXY ACIDS LILLY INDUSTRIES LIMITED (GB) 1985-04-23 US disclosed
EP-0068739-B1 SULPHUR-CONTAINING 5-HYDROXY-ALKANOIC ACID DERIVATIVES, THEIR USE AS PHARMACEUTICAL PREPARATIONS AND PROCESS FOR THEIR PRODUCTION Lilly Industries Limited (GB) 1984-11-14 EP disclosed
EP-0068739-A1 Sulphur-containing 5-hydroxy-alkanoic acid derivatives, their use as pharmaceutical preparations and process for their production Lilly Industries Limited (GB) 1983-01-05 EP disclosed